IO Biotech, Inc.IOBTNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank32
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P32
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -17.48% |
| Q2 2025 | 1.69% |
| Q1 2025 | -22.57% |
| Q4 2024 | 4.80% |
| Q3 2024 | 27.32% |
| Q2 2024 | 10.74% |
| Q1 2024 | -34.26% |
| Q4 2023 | 23.31% |
| Q3 2023 | 6.97% |
| Q2 2023 | 38.69% |
| Q1 2023 | -17.55% |
| Q4 2022 | 44.01% |
| Q3 2022 | -18.03% |
| Q2 2022 | 18.63% |
| Q1 2022 | -37.31% |
| Q4 2021 | 298.26% |
| Q3 2021 | -38.71% |
| Q2 2021 | 136.48% |
| Q1 2021 | 28.87% |
| Q4 2020 | -20.42% |
| Q3 2020 | 59.78% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |